Coronary heart disease risk factors and mortality [1]

JAMA

Volumn 307, Issue 11, 2012, Pages 1137-

  Santulli, Gaetano ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; LIPID;

BLOOD PRESSURE; CARDIOVASCULAR RISK; CORONARY RISK; DISEASE ASSOCIATION; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HEART INFARCTION SIZE; HUMAN; ISCHEMIC HEART DISEASE; LETTER; LIPID BLOOD LEVEL; METABOLIC SYNDROME X; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

EID: 84858636345     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2012.323     Document Type: Letter

References (5)

1. Canto JG, Kiefe CI, Rogers WJ, et al NRMI Investigators. Number of coronary heart disease risk factors and mortality in patients with first myocardial infarction. JAMA. 2011;306(19):2120-2127.
2. D'Agostino RB Sr, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117(6):743-753. (Pubitemid 351640675)
3. Petersen JL, Yow E, AlJaroudi W, et al. Metabolic syndrome is not associated with increased mortality or cardiovascular risk in nondiabetic patients with a new diagnosis of coronary artery disease. Circ Cardiovasc Qual Outcomes. 2010;3(2):165-172.
4. Wu E, Ortiz JT, Tejedor P, et al. Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study. Heart. 2008;94(6):730-736. (Pubitemid 351744690)
5. Wang TJ, Gona P, Larson MG, et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med. 2006;355(25):2631-2639 (Pubitemid 44969122)